Medical Education

August 2007
August 2007
Med Ed Report: CME's Open Gesture
Eli Lilly revealed its educational grants in an online database. The transparency wave may be gathering steam, with other firms, as well as patient groups and  societies, saying they may make grants public, too. Will the efforts help restore trust in CME? Marc Iskowitz reports


Medical Education Review 2007
What are the biggest challenges for medical education providers? What types of programs are growing fastest, and why? What is happening to commercial support? Are grant approvals speeding up? Find out the answers to these questions and more in MM&M's annual survey. PLUS: detailed listings of the offerings and contacts of more than 120 medical education companies
Medical Ed Report: CME's Open Gesture (Download the PDF)

Medical Education Review 2007 (Download the PDF)
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.